Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre
Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2017/4697194 |
id |
doaj-0308cd1af8d1439fbcad1a03091b9ace |
---|---|
record_format |
Article |
spelling |
doaj-0308cd1af8d1439fbcad1a03091b9ace2020-11-25T01:24:59ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972017-01-01201710.1155/2017/46971944697194Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single CentreVi Nguyen0Jiawei Li1Jaslyn Gan2Paul Cordero3Shuvra Ray4Alessandro Solis-Cuevas5Mai Khatib6Jude A. Oben7Institute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKInstitute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKInstitute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKInstitute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKInstitute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKDepartment of Biological Sciences, University College London, Gower St., Bloomsbury, London WC1E 6BT, UKDepartment of Biological Sciences, University College London, Gower St., Bloomsbury, London WC1E 6BT, UKInstitute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UKBackground. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m2; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m2, resp., p<0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.http://dx.doi.org/10.1155/2017/4697194 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vi Nguyen Jiawei Li Jaslyn Gan Paul Cordero Shuvra Ray Alessandro Solis-Cuevas Mai Khatib Jude A. Oben |
spellingShingle |
Vi Nguyen Jiawei Li Jaslyn Gan Paul Cordero Shuvra Ray Alessandro Solis-Cuevas Mai Khatib Jude A. Oben Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre Canadian Journal of Gastroenterology and Hepatology |
author_facet |
Vi Nguyen Jiawei Li Jaslyn Gan Paul Cordero Shuvra Ray Alessandro Solis-Cuevas Mai Khatib Jude A. Oben |
author_sort |
Vi Nguyen |
title |
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre |
title_short |
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre |
title_full |
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre |
title_fullStr |
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre |
title_full_unstemmed |
Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre |
title_sort |
outcomes following serial intragastric balloon therapy for obesity and nonalcoholic fatty liver disease in a single centre |
publisher |
Hindawi Limited |
series |
Canadian Journal of Gastroenterology and Hepatology |
issn |
2291-2789 2291-2797 |
publishDate |
2017-01-01 |
description |
Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m2; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m2, resp., p<0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change. |
url |
http://dx.doi.org/10.1155/2017/4697194 |
work_keys_str_mv |
AT vinguyen outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT jiaweili outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT jaslyngan outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT paulcordero outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT shuvraray outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT alessandrosoliscuevas outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT maikhatib outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre AT judeaoben outcomesfollowingserialintragastricballoontherapyforobesityandnonalcoholicfattyliverdiseaseinasinglecentre |
_version_ |
1725115880740749312 |